Mitchell J. Blutt, MD

Board of Directors

Mitchell J. Blutt

Mitchell Blutt, MD is the CEO of Consonance Capital, a health care focused investment firm. He is the former Executive Partner of J.P. Morgan Partners (JPMP). He is also a Clinical Assistant Professor of Medicine, in the Department of Medicine at Weill Cornell Medicine.

Dr. Blutt completed his BA and MD degrees from the University of Pennsylvania. He received his MBA at the Wharton School of the University of Pennsylvania through the Clinical Scholars Fellowship sponsored by the Robert Wood Johnson Foundation. He completed his residency in Internal Medicine at New York- Presbyterian/Weill Cornell Medical Center.

Dr. Blutt has served on numerous boards of directors, including Cardinal Health, Cooper Holding, DJ Orthopedics, Fisher Scientific, General Medical, Hanger Orthopedic Group, Medical Arts Press, Tenax, Thermoscan and KEPRO. He also formerly served on the Board of the Michael J. Fox Foundation for Parkinson’s Research, the Board of Trustees of Penn Medicine (the Health System of the University of Pennsylvania), the Board of Trustees of the University of Pennsylvania, and the Board of The Brearley School. He currently serves on the Board of Overseers of the University of Pennsylvania School of Arts and Sciences and is the Chairman of the External Advisory Board of CHIBE (Center for Health Incentives and Behavioral Economics) at the University of Pennsylvania. Dr. Blutt is a recipient of the Alumni Award of Merit, the University of Pennsylvania’s highest honor. He is also on the Executive Committee of the Dean’s Council, an advisory board to the Dean at Weill Cornell Medicine, and a member of the New York Weill Cornell Council, an advisory board to the New York-Presbyterian/Weill Cornell Medical Center. He serves on the Board of Directors of The Commonwealth Fund, a private foundation that supports independent research on health and social issues and makes grants to improve health care practice and policy. Dr. Blutt also serves on the Board of Bako, a premier national provider of specialty laboratory testing and other high quality pathology services.

Dr. Blutt founded Consonance Capital in 2005.